1 / 140

Chapter 14 Pharmaceuticals

Chapter 14 Pharmaceuticals. CHM 585 / 490. Pharmaceuticals. Industry Synthetic Considerations Nabumetone Methotrexate Natural Products Antidepressants Antihistamines Chirality cGMP. 10,300 FDA approved drugs in U.S.

kiet
Download Presentation

Chapter 14 Pharmaceuticals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chapter 14Pharmaceuticals CHM 585 / 490

  2. Pharmaceuticals • Industry • Synthetic Considerations • Nabumetone • Methotrexate • Natural Products • Antidepressants • Antihistamines • Chirality • cGMP

  3. 10,300 FDA approved drugs in U.S. • 50% of all new drugs currently available worldwide have been launched in the U.S. • The discovery/preclinical stage takes from 3–7 years and only about 1 of every 10,000 compounds evaluated enters human trials Drug Discovery and Development November 2002

  4. Top 10 Pharma Companies by 2002 Revenues ($B) Leaders of Life Sciences Dec 2003

  5. GlaxoSmithKline • Paxil (SSRI -selective serotonin reuptake inhibitor – depression) • Advaire (for asthma) • Augmentin (for asthma) • Augmentin (antibiotic) • Avandia (diabetes) • Combivir (HIV) • Flonase (allergies) • Imitrex ( migraines)

  6. Pfizer • Lipitor (#1 prescribed drug) (cholesterol) $8.6B in revenue • Norvasc (hypertension) • Zoloft (SSRI)

  7. Merck • Zocor (cholesterol) • Vioxx (osteoarthritis – joint disease) • Fosamax (osteoporosis – bone loss) • Cozaar (hypertension) • Singulair (asthma)

  8. About 12 Years to bring a drug to market

  9. $ • Cost for a single new drug averages $1.7 B C & EN December 15, 2003

  10. 2003 • $33 B invested in Pharma Research • 86 new medicines • 21 new molecular entities (NMEs) • 14 biologics • 51 additional drugs • Over the past 20 years, for every dollar invested in health care, between $2.40 - $3.00 in gains have been realized R&D Magazine March 2004

  11. Top Reasons for Drug Recalls in 2001 • Deviations from cGMP • Subpotency • Stability data failed to support expiration data • Failure of drug to dissolve properly • Wrong packaging • Incorrect labeling • Microbial contamination Drug Discovery and Development November 2002

  12. Pharmaceuticals • Industry • Synthetic Considerations • Nabumetone • Methotrexate • Natural Products • Antidepressants • Antihistamines • Chirality • cGMP

  13. Nabumetone • See handout for various syntheses and discussion on this NSAID

  14. Multistep Syntheses • Even when each step is a high yield step, the overall yield can be low. • For example a 5 step synthesis where each step is a 90% yield reaction has an overall yield of 59% • 0.90 x 0.90 x 0.90 x 0.90 x 09.0 = 0.59

  15. $ • For an effective cost position, important to have: • As few steps as possible • High yield reactions • Clean reactions – separation of impurities is critical for pharmaceuticals and can be difficult when impurities are structurally similar to desired product.

  16. Methotrexate

  17. MethotrexateConvergent Synthesis

  18. Pharmaceuticals • Industry • Synthetic Considerations • Nabumetone • Methotrexate • Natural Products • Antidepressants • Antihistamines • Chirality • cGMP

  19. “ Natural Products” • Heparin • Premarin • Taxol

  20. Heparin • Anticoagulant • By extracting the intestines of pigs • Used for ~ 70 years

  21. Lovenox – low molecular weight heparin by Aventis STRUCTURAL FORMULA Fragmin (Pfizer) – another low molecular weight heparin

  22. Warafin (Coumadin®) Heparin Clopidogrel (Plavix®) Dipyridamole (Persantine®) Enoxaparin (Lovenox®) Ardeparin (Normiflo®) Dalteparin (Fragmin®) Ticlopidine (Ticlid®) Danaparoid (Orgaran®) Tinzaparin (Innohep®) Aspirin Thrombin Inhibitors Commonly Prescribed Anticoagulants

  23. Premarin • Number 1 drug of 1999 list • Steroid • Estrogen drug used for menopause • Made from urine of pregnant horses • Pregnant Mare Urine

  24. Steroids • Steroid is a general term for a large number of naturally occurring materials found in plants and animals.

  25. Taxol • From the bark of the Pacific Yew tree • Anticancer drug

  26. Pharmaceuticals • Industry • Synthetic Considerations • Nabumetone • Methotrexate • Natural Products • Antidepressants • Antihistamines • Chirality • cGMP

  27. Classes of Antidepressants • There are five classes of antidepressants • Tricyclics (TCA) • Monoamine Oxidase Inhibitors (MAOIs) • Second-Generation (Atypical) Antidepressants or Heterocyclics • Serotonin-Specific Reuptake Inhibitors (SSRI) • Dual-Action Antidepressants

  28. Tricyclics (TCAs) • One of the first classes of antidepressants developed were the tricyclics. • Tricyclics produce a sedative effect by blocking the passage of norepinephrine and serotonin in and out of nerve endings.

  29. TCAs • Structures: • Imipramine HCL Amitriptyline HCL Nortriptyline HCL C 19H24N2 HCL C20H23N HCL C19H21N HCL mw: 316.88 mw: 313.86 mw: 299.84 (11)

  30. MAOI (MonoAmine Oxidase Inhibitors) Early treatments for depression

  31. Serotonin-Specific Reuptake Inhibitors (SSRIs) • SSRIs were discovered in the 1980s • They are better tolerated than some other antidepressants, with less severe side effects and have a wide margin of safety in overdose. • SSRIs inhibit the reuptake of serotonin into the presynaptic neuron. (17)

  32. SSRIs • Some examples of SSRIs: 1. Paroxetine (Paxil®) - 1992 2. Fluvoxamine (Luvox®) - 1994 3. Clomipramine (Anafranil®) - 1990 4. Sertraline (Zoloft®) - 1991 5. Fluoxetine (Prozac®) - 1987 6. Venlafaxine (Effexor®) - 1993 7. Citalopram (Celexa®) - 1998 (1)

  33. SSRIs - Paxil® • Used for • Depression • OCD (Obsessive Compulsive Disorder) • Social Anxiety • Generates sales in excess of $1.5 billion/year (2000)

  34. SSRIs - Prozac® Fluoxetine Hydrochloride

  35. SSRIs - Prozac® • First SSRI to be put out on the market. • Indications: • Depression • Obsessive compulsive disorder (OCD) • Bulimia • Others (unlabeled uses) • Sales of Prozac reached 1.2 billion in 1995 and in 2000 reached 2.7 billion for Eli Lilly.

  36. SSRIs - Prozac® • Patents • The original synthesis patents were 4,314,081 and 4,194,009 and were approved in 1982 and 1980, respectively, to Eli Lilly and Company. • Synthesis patent 6,028,224 in 2000 to Sepracor Inc. • Other patents owned by Eli Lilly are: • 4,018,985, 4,313,896, 4,590,213, and 4,626,549 • Patents owned by AAI: • 6,258,853, 6,310,250, and 6,310,251

  37. SSRIs-Zoloft® • Zoloft® is primarily used to treat: • Major depressive disorder • Obsessive/Compulsive disorder (OCD) • Panic disorder • Post-traumatic stress disorder • Manufactured by Pfizer, Inc. • Blocks the uptake of serotonin into human platelets

  38. Pharmaceuticals • Industry • Synthetic Considerations • Nabumetone • Methotrexate • Natural Products • Antidepressants • Antihistamines • Chirality • cGMP

  39. Histamine • Histamine acts upon two sites in the body, H1 and H2 sites. H2 sites are located in the gastrointestinal system and H1 sites are located in the respiratory system. • AntihistamineMedication that prevents symptoms of congestion, sneezing, and itchy, runny nose by blocking histamine receptors.

  40. Antihistamines • First generation • Chlor Trimetron • Benadryl • Second generation • Do not cause sedation • Do not cross the blood-brain barrier

  41. First Generation Antihistamines(Alkylamines) • Chlorpheniramine maleate (Chlor Trimeton®) • Schering (1949) • Currently sold OTC by Schering-Plough Healthcare Products

  42. First Generation Antihistamines (Ethanolamines) • Diphenhydramine HCl (Benadryl®) • Parke Davis (1946) • Currently sold OTC by Pfizer, Inc., Warner -Lambert Consumer Healthcare

  43. Second Generation Antihistamines • Terfenadine (Seldane®) • Marion Merrell Dow • FDA approved in 1985

  44. Second Generation Antihistamines • Terfenadine (Seldane®) • Developed from Haloperidol • Haloperidol - antipsychotic drug having antihistaminic properties • Replaced the phenyl ketone group with phenyl butanol group to inhibit the capability of the drug to pass through the blood-brain barrier

  45. Second Generation Antihistamines Terfenadine Haloperidol

  46. Second Generation Antihistamines • Terfenadine (Seldane®) • Non-sedating • Caused potentially fatal heartbeat irregularities when taken with certain drugs and foods (1992) • Ketoconozole, erithromycin, grapefruit juice interfered with drug metabolism increasing the concentration of terfenadine in bloodstream • Racemic mixture • One enantiomer caused cardiac toxicity • Removed from market (1997)

More Related